imr-687
Showing 1 - 5 of 5
Heart Failure With Preserved Ejection Fraction Trial (IMR-687, IMR-687 Placebo)
Withdrawn
- Heart Failure With Preserved Ejection Fraction
- IMR-687
- IMR-687 Placebo
- (no location specified)
May 23, 2022
Sickle Cell Disease Trial in United Kingdom, United States (IMR-687)
Active, not recruiting
- Sickle Cell Disease
- IMR-687
-
Farmington, Connecticut
- +6 more
Mar 2, 2022
Sickle Cell Disease Trial in Worldwide (IMR-687, Placebo)
Terminated
- Sickle Cell Disease
- IMR-687
- Placebo
-
Birmingham, Alabama
- +48 more
May 9, 2022
Sickle Cell Disease, Sickle-Cell; Hb-SC, Sickle Beta 0 Thalassemia Trial in Overland Park (IMR-687, Placebo Oral Capsule)
Completed
- Sickle Cell Disease
- +2 more
- IMR-687
- Placebo Oral Capsule
-
Overland Park, KansasQuintiles
May 31, 2018